ALB and hepatocellular carcinoma: An increased risk of 2.5 times was found in patients with AFP levels between 20 and 400 ng/mL, while a threefold increase in risk was observed in HCC patients with albumin levels less than 3.5 g/dl (Tables 11 and 12).